Updated Jul 16, 2026
Williams Laura A has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.14M.
Laura A. Williams is the Chief Medical Officer and Chief Patient Officer at Ardelyx, Inc., a biopharmaceutical company focused on developing innovative therapies. She has been involved in multiple SEC filings related to her roles within the company.
| Role | Chief Patient Officer |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | ARDX | ARDELYX, INC. | S — Open-market sale | 81.9K | $5.99 | $490K |
| 2026-06-22 | ARDX | ARDELYX, INC. | M — Option exercise | 31.0K | $0.99 | $31K |
| 2026-05-22 | ARDX | ARDELYX, INC. | S — Open-market sale | 1.4K | $6.27 | $9K |
| 2026-05-22 | ARDX | ARDELYX, INC. | S — Open-market sale | 1.9K | $6.27 | $12K |
| 2026-05-22 | ARDX | ARDELYX, INC. | S — Open-market sale | 2.2K | $6.27 | $14K |
| 2026-05-22 | ARDX | ARDELYX, INC. | S — Open-market sale | 1.5K | $6.27 | $9K |
| 2026-02-24 | ARDX | ARDELYX, INC. | S — Open-market sale | 984 | $5.71 | $6K |
| 2026-02-24 | ARDX | ARDELYX, INC. | S — Open-market sale | 7.2K | $5.87 | $42K |
| 2026-01-26 | ARDX | ARDELYX, INC. | A — Grant or award | 82.7K | $0.00 | |
| 2025-08-26 | ARDX | ARDELYX, INC. | S — Open-market sale | 30.0K | $6.12 | $184K |
| 2025-08-26 | ARDX | ARDELYX, INC. | S — Open-market sale | 50.0K | $6.12 | $306K |
| 2025-08-26 | ARDX | ARDELYX, INC. | M — Option exercise | 50.0K | $0.99 | $50K |
| 2025-08-21 | ARDX | ARDELYX, INC. | S — Open-market sale | 6.3K | $5.93 | $37K |
| 2024-11-22 | ARDX | ARDELYX, INC. | S — Open-market sale | 7.4K | $4.79 | $35K |
Laura A. Williams is the Chief Medical Officer and Chief Patient Officer at Ardelyx, Inc., a biopharmaceutical company focused on developing innovative therapies. She has been involved in multiple SEC filings related to her roles within the company.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 11 open-market sales ($1.14M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Williams Laura A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.